Weight gain following the initiation or the switch of antiretroviral therapy (ART) is well documented and mainly associated with some of the most recent drugs, such as integrase strand transfer inhibitors and tenofovir alafenamide. However, limited data have been published on weight trends in ART-experienced people living with HIV (PLWH) with a long exposure to HIV infection and antiretroviral drugs. In our study, we assessed changes in weight after switching ART among PLWH who reported weight gain under a previous regimen.
Should we expect weight changes in people with HIV and a reported weight gain only by switching antiretroviral therapy? / Muccini, C.; Ceccarelli, D.; Lolatto, R.; Spagnuolo, V.; Oltolini, C.; Danise, A.; Mainardi, I.; Monardo, R.; Castagna, A.. - In: NEW MICROBIOLOGICA. - ISSN 1121-7138. - 46:1(2023), pp. 65-67.
Should we expect weight changes in people with HIV and a reported weight gain only by switching antiretroviral therapy?
Muccini C.Primo
;Spagnuolo V.;Mainardi I.;Monardo R.Penultimo
;Castagna A.Ultimo
2023-01-01
Abstract
Weight gain following the initiation or the switch of antiretroviral therapy (ART) is well documented and mainly associated with some of the most recent drugs, such as integrase strand transfer inhibitors and tenofovir alafenamide. However, limited data have been published on weight trends in ART-experienced people living with HIV (PLWH) with a long exposure to HIV infection and antiretroviral drugs. In our study, we assessed changes in weight after switching ART among PLWH who reported weight gain under a previous regimen.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
